CEBPB and hepatocellular carcinoma: With multiple enhancers (3 out of 27) targeted C/EBPβ and a high eRNA-mRNA correlation of 0.863 across 808 FANTOM5 samples, the selected highly confident enhancer-target pair exhibited significant hypomethylation-associated gene upregulation in HCC tumors (Supplementary Table 1).